Related references
Note: Only part of the references are listed.The (non-)sense of detecting anti-cardiolipin and anti-β2glycoprotein I IgM antibodies in the antiphospholipid syndrome
Walid Chayoua et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Detection of anti-domain I antibodies by chemiluminescence enables the identification of high-risk antiphospholipid syndrome patients: A multicenter multiplatform study
Dongmei Yin et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Lupus anticoagulant assay cut-offs vary between reagents even when derived from a common set of normal donor plasmas
Gary W. Moore et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Antiphosphatidylserine/Prothrombin Antibodies: An Update on Their Association with Clinical Manifestations of Antiphospholipid Syndrome
Massimo Radin et al.
THROMBOSIS AND HAEMOSTASIS (2020)
Lupus anticoagulant detection in anticoagulated patients. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis
Armando Tripodi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Evaluation of an automated algorithm for interpretation of lupus anticoagulant testing
Lisa Florin et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2019)
Detection of Anti-Cardiolipin and Anti-β2glycoprotein I Antibodies Differs between Platforms without Influence on Association with Clinical Symptoms
Walid Chayoua et al.
THROMBOSIS AND HAEMOSTASIS (2019)
EULAR recommendations for the management of antiphospholipid syndrome in adults
Maria G. Tektonidou et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Resolving DOAC interference on aPTT, PT, and lupus anticoagulant testing by the use of activated carbon
Glynis Frans et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
IgG phosphatidylserine/prothrombin antibodies as a risk factor of thrombosis in antiphospholipid antibody carriers
Marta Tonello et al.
THROMBOSIS RESEARCH (2019)
Neutralising rivaroxaban induced interference in laboratory testing for lupus anticoagulant (LA): A comparative study using DOAC Stop and andexanet alfa
Emmanuel J. Favaloroa et al.
THROMBOSIS RESEARCH (2019)
Extended persistence of antiphospholipid antibodies beyond the 12-week time interval: Association with baseline antiphospholipid antibodies titres
Jean Devignes et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2019)
Clinical and laboratory practice for lupus anticoagulant testing: An International Society of Thrombosis and Haemostasis Scientific and Standardization Committee survey
Hannah Cohen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Influence of DOAC Stop on coagulation assays in samples from patients on rivaroxaban or apixaban
Sean Platton et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2019)
Improvements in diagnosis and risk assessment of primary and secondary antiphospholipid syndrome
Michelle Petri
Hematology-American Society of Hematology Education Program (2019)
Influence of anticardiolipin and anti-β2 glycoprotein I antibody cutoff values on antiphospholipid syndrome classification
Laura Vanoverschelde et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2019)
Antiphospholipid syndrome and IgA anti-beta2-glycoprotein I antibodies: when Cinderella becomes a princess
D. Perez et al.
LUPUS (2018)
Laboratory Diagnostics of Antiphospholipid Syndrome
Vittorio Pengo et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2018)
Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH
K. M. J. Devreese et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Laboratory criteria for antiphospholipid syndrome: reply
K. M. J. . Devreese et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Diagnosis and Management of the Antiphospholipid Syndrome
David Garcia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Clinical and laboratory characteristics of isolated lupus anticoagulants
E. Mattia et al.
THROMBOSIS RESEARCH (2018)
Simple method for removing DOACs from plasma samples
T. Exner et al.
THROMBOSIS RESEARCH (2018)
Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-β2glycoprotein I antibody detection assays
W. Chayoua et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
The clinical value of assays detecting antibodies against domain I of beta 2-glycoprotein I in the antiphospholipid syndrome
Dongmei Yin et al.
AUTOIMMUNITY REVIEWS (2018)
Lupus anticoagulant identifies two distinct groups of patients with different antibody patterns
V. Pengo et al.
THROMBOSIS RESEARCH (2018)
Prevalence and Significance of Non-conventional Antiphospholipid Antibodies in Patients With Clinical APS Criteria
Elena Litvinova et al.
FRONTIERS IN IMMUNOLOGY (2018)
A multicenter study to assess the reproducibility of antiphospholipid antibody results produced by an automated system
K. M. Devreese et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Variability of cut-off values for the detection of lupus anticoagulants: results of an international multicenter multiplatform study
A. Tripodi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Pathogenesis and management of antiphospholipid syndrome
Deepa R. J. Arachchillage et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Detection of lupus anticoagulant in the era of direct oral anticoagulants
Ariela Hoxha et al.
AUTOIMMUNITY REVIEWS (2017)
Dilute Russell's viper venom time reagents in lupus anticoagulant testing: a well-considered choice
Barbara Depreter et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2017)
Analytical and clinical comparison of different immunoassay systems for the detection of antiphospholipid antibodies
B. Montaruli et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2016)
Role of anti-domain 1-β2glycoprotein I antibodies in the diagnosis and risk stratification of antiphospholipid syndrome
A. -S. De Craemer et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
IgG/IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: a critical review of their association with thrombosis
H. Kelchtermans et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Lupus-anticoagulant testing at NOAC trough levels
Franz Ratzinger et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Changes in Antiphospholipid Antibody Titers During Pregnancy: Effects on Pregnancy Outcomes
Cecile M. Yelnik et al.
ARTHRITIS & RHEUMATOLOGY (2016)
A Clinical Approach for Defining the Threshold between Low and Medium Anti-Cardiolipin Antibody Levels for QUANTA Flash Assays
Gabriella Lakos et al.
ANTIBODIES (2016)
Increased mortality in patients with the lupus anticoagulant: the Vienna Lupus Anticoagulant and Thrombosis Study (LATS)
Johanna Gebhart et al.
BLOOD (2015)
The addition of idarucizumab to plasma samples containing dabigatran allows the use of routine coagulation assays for the diagnosis of hemostasis disorders
M. Jacquemin et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Antiphospholipid syndrome: antibodies to Domain 1 of β2-glycoprotein 1 correctly classify patients at risk
V. Pengo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: A systematic review and meta-analysis
Quitterie Reynaud et al.
AUTOIMMUNITY REVIEWS (2014)
Antiphospholipid antibody testing and standardization
K. M. J. Devreese
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2014)
Testing for Antiphospholipid antibodies with Solid Phase Assays: guidance from the SSC of the ISTH
K. M. J. Devreese et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study
P. Mustonen et al.
LUPUS (2014)
Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome
Savino Sciascia et al.
THROMBOSIS AND HAEMOSTASIS (2014)
The clinical relevance of IgA anticardiolipin and IgA anti-β2 glycoprotein I antiphospholipid antibodies A systematic review
Hector Meijide et al.
AUTOIMMUNITY REVIEWS (2013)
Cooperation experience in a multicentre study to define the upper limits in a normal population for the diagnostic assessment of the functional lupus anticoagulant assays
Paola Pradella et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2013)
Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile
V. Pengo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Diagnosis of antiphospholipid syndrome in routine clinical practice
C. Gardiner et al.
LUPUS (2013)
Variability in Exposure of Epitope G40-R43 of Domain I in Commercial Anti-Beta2-Glycoprotein I IgG ELISAs
Leonie Pelkmans et al.
PLOS ONE (2013)
GAPSS: the Global Anti-Phospholipid Syndrome Score
Savino Sciascia et al.
RHEUMATOLOGY (2013)
Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies
Michael D. Lockshin et al.
ARTHRITIS AND RHEUMATISM (2012)
Guidelines on the investigation and management of antiphospholipid syndrome
David Keeling et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Performance of two new, automated chemiluminescence assay panels for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome
F. Van Hoecke et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2012)
Clinical accuracy for diagnosis of antiphospholipid syndrome in systemic lupus erythematosus: evaluation of 23 possible combinations of antiphospholipid antibody specificities
S. Sciascia et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Standardization of antiphospholipid antibody assays. Where do we stand?
K. M. J. Devreese
LUPUS (2012)
Internal Quality Control and External Quality Assurance in Testing for Antiphospholipid Antibodies: Part I-Anticardiolipin and Anti-β2-Glycoprotein I Antibodies
Emmanuel J. Favaloro et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2012)
Internal Quality Control and External Quality Assurance in Testing for Antiphospholipid Antibodies: Part II-Lupus Anticoagulant
Emmanuel J. Favaloro et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2012)
What Have We Learned about Antiphospholipid Syndrome from Patients and Antiphospholipid Carrier Cohorts?
Vittorio Pengo et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2012)
Antiphospholipid antibodies: Evaluation of the thrombotic risk
Katrien M. J. Devreese
THROMBOSIS RESEARCH (2012)
Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study
Vittorio Pengo et al.
BLOOD (2011)
Diagnostic test combinations associated with thrombosis in lupus anticoagulant positive patients
Katrien Devreese et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Lupus Anticoagulant Testing Performance and Practices by North American Clinical Laboratories
Francine R. Dembitzer et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2010)
Thrombotic risk assessment in the antiphospholipid syndrome requires more than the quantification of lupus anticoagulants
Katrien Devreese et al.
BLOOD (2010)
Challenges in the Diagnosis of the Antiphospholipid Syndrome
Katrien Devreese et al.
CLINICAL CHEMISTRY (2010)
Clinical course of high-risk patients diagnosed with antiphospholipid syndrome
V. Pengo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Lupus Anticoagulant (LAC) testing in patients with inflammatory status: Does C-reactive protein interfere with LAC test results?
Sofie M. E. Schouwers et al.
THROMBOSIS RESEARCH (2010)
Laboratory diagnosis of the antiphospholipid syndrome: a plethora of obstacles to overcome
Katrien Devreese et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
Update of the guidelines for lupus anticoagulant detection
V. Pengo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study
B. De Laat et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study
Rolf T. Urbanus et al.
LANCET NEUROLOGY (2009)
Laboratory criteria of the obstetrical antiphospholipid syndrome Data from a multicentric prospective European women cohort
Marie-Claire Boffa et al.
THROMBOSIS AND HAEMOSTASIS (2009)
Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study
Monica Galli et al.
BLOOD (2007)
Anti phospholipid antibody ELISAs: Survey on the performance of clinical laboratories assessed by using lyophilized affinity-purifled IgG with anticardiolipin and anti-beta 2-glycoprotein I activity
Vittorio Pengo et al.
THROMBOSIS RESEARCH (2007)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
IgG antibodies that recognize epitope Gly40-Arg43 in domain I of β2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis
B de Laat et al.
BLOOD (2005)
Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature
M Galli et al.
BLOOD (2003)
Share Paper
